Phase II study of oral miltefosine in patients with squamous cell head and neck cancer.
Verweij
J
J
Gandia
D
D
Planting
A S
AS
Stoter
G
G
Armand
J P
JP
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D010767:Phosphorylcholine; C039128:miltefosine